Adjunctive Cefiderocol Treats Native Aortic Valve Gram Negative Endocarditis

Cefiderocol, a novel siderophore cephalosporin, may be successful in patients with persistently bacteremic nosocomial native aortic valve endocarditis.

Source link

Related posts

The Failing Right Ventricle: Where Do We go from Here.


Glycemic Variability May Predict Incident Cardiovascular Disease, Mortality


Hayden’s Heart Monthly Beat- APRIL


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World